Sequencing of Candidate Chromosome Instability Genes in Endometrial Cancers Reveals Somatic Mutations in ESCO1, CHTF18, and MRE11A

• Jessica C. Price,

  Affiliation Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Lana M. Pollock,

  Affiliation Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Meghan L. Rudd,

  Affiliation Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Sarah K. Fogoros,

  Affiliation Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Hassan Mohamed,

  Affiliation Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Christin L. Hanigan,

  Affiliation Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Matthieu Le Gallo,

  Affiliation Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• NIH Intramural Sequencing Center (NISC) Comparative Sequencing Program,

  Affiliation Intramural Sequencing Center, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Suiyuan Zhang,

  Affiliation Genome Technology Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Pedro Cruz,

  Affiliation Genome Technology Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Praveen F. Cherukuri,

  Affiliation Genome Technology Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Nancy F. Hansen,

  Affiliation Genome Technology Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Kirk J. McManus,

  Affiliation Department of Biochemistry and Medical Genetics, University of Manitoba, Manitoba Institute of Cell Biology, Winnipeg, Manitoba, Canada

  ⨯
• Andrew K. Godwin,

  Affiliations Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas, United States of America, The University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, Kansas, United States of America

  ⨯
• Dennis C. Sgroi,

  Affiliation Molecular Pathology Unit and Center for Cancer Research, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America

  ⨯
• James C. Mullikin,

  Affiliations Intramural Sequencing Center, National Institutes of Health, Bethesda, Maryland, United States of America, Genome Technology Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Maria J. Merino,

  Affiliation Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Philip Hieter,

  Affiliation Michael Smith Laboratories, University of British Columbia, Vancouver, British Columbia, Canada

  ⨯
•  [ ... ],
• Daphne W. Bell

  * E-mail: belldaph@mail.nih.gov

  Affiliation Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• [ view all ]
• [ view less ]